Pharma73 Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Buyout/​LBO
  • Investors
  • 1

Pharma73 General Information


Provider of a biopolymer production technology platform intended to be used as novel excipients for the pharmaceutical, cosmetics and food industries. The company's biopolymer production technology platform includes natural biopolymer products whose unique properties enable their use as high functionality excipients enabling clients to develop, produce and commercialize a new generation of enhanced performance High Functionality Excipients (HFE's).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare
Other Industries
Medical Supplies
Primary Office
  • Homestead Burrazeiro River Mill
  • River Mill, 7150-390
  • Portugal
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharma73 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO 22-Nov-2016 Completed Startup
2. Later Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Pharma73’s complete valuation and funding history, request access »

Pharma73 Executive Team (2)

Name Title Board Seat Contact Info
Pedro Manuel Vilarinho Ph.D Chief Executive Officer
Filipe Aguiar Chief Business Development Officer
To view Pharma73’s complete executive team members history, request access »

Pharma73 Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tau Capital (Douglas) PE/Buyout Majority 000 0000 000000 0
To view Pharma73’s complete investors history, request access »